{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:21:27Z","timestamp":1778898087343,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","award":["1931F"],"award-info":[{"award-number":["1931F"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013347","name":"European Society of Intensive Care Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jcrc.2025.155101","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:44:19Z","timestamp":1746488659000},"page":"155101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Reversal of antithrombotics in the critically ill: An international online survey"],"prefix":"10.1016","volume":"89","author":[{"given":"Stefan F.","family":"van Wonderen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite M.T.","family":"van Haeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna C.","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.W.","family":"Oczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Aubron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Gratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo G.","family":"Abbasciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole P.","family":"Juffermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander P.J.","family":"Vlaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella C.A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2025.155101_bb0005","series-title":"Physiology, Coagulation Pathways","author":"Chaudhry","year":"2022"},{"issue":"2 Suppl","key":"10.1016\/j.jcrc.2025.155101_bb0010","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/CCM.0b013e3181c9e344","article-title":"Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients","volume":"38","author":"Cook","year":"2010","journal-title":"Crit. Care Med."},{"issue":"22","key":"10.1016\/j.jcrc.2025.155101_bb0015","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv."},{"issue":"13","key":"10.1016\/j.jcrc.2025.155101_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"23 Pt A","key":"10.1016\/j.jcrc.2025.155101_bb0025","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","article-title":"ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison","volume":"72","author":"Capodanno","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.jcrc.2025.155101_bb0030","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.jcrc.2025.155101_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/CCM.0000000000004206","article-title":"Impact of anticoagulation on mortality and resource utilization among critically ill patients with major bleeding","volume":"48","author":"Fernando","year":"2020","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jcrc.2025.155101_bb0040","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: guidance from the anticoagulation forum","volume":"94","author":"Cuker","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"22","key":"10.1016\/j.jcrc.2025.155101_bb0045","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMra1206531","article-title":"Management of antithrombotic therapy in patients undergoing invasive procedures","volume":"368","author":"Baron","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jcrc.2025.155101_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of Antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical care society and Society of Critical Care Medicine","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit. Care"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155101_bb0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","article-title":"2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution set Oversight Committee","volume":"76","author":"Tomaselli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.jcrc.2025.155101_bb0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.chest.2022.08.004","article-title":"Executive summary: perioperative management of antithrombotic therapy: an American College of Chest Physicians Clinical Practice Guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155101_bb0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jama.2024.5880","article-title":"Perioperative management of antithrombotic therapy","volume":"332","author":"Lyons","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155101_bb0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1807320","article-title":"Randomized trial of platelet-transfusion thresholds in neonates","volume":"380","author":"Curley","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10038","key":"10.1016\/j.jcrc.2025.155101_bb0075","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155101_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40560-023-00701-3","article-title":"Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study","volume":"11","author":"Saito","year":"2023","journal-title":"J. Intensive Care"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155101_bb0085","first-page":"305","article-title":"Accuracy of aPTT monitoring in critically ill patients treated with unfractionated heparin","volume":"72","author":"van Roessel","year":"2014","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.jcrc.2025.155101_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2019.01.002","article-title":"Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin","volume":"175","author":"Ratano","year":"2019","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.jcrc.2025.155101_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/ALN.0000000000004787","article-title":"Monitoring of Argatroban in critically ill patients: a prospective study comparing activated partial thromboplastin time, point-of-care viscoelastic testing with Ecarin clotting time and diluted thrombin time to mass spectrometry","volume":"140","author":"Heubner","year":"2024","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155101_bb0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Subcommittee on control of anticoagulation of the S, standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jcrc.2025.155101_bb0105","series-title":"RStudio: Integrated Development Environment for R","author":"RStudio Team","year":"2022"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155101_bb0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/rth2.12320","volume":"4","author":"Levy","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"issue":"2","key":"10.1016\/j.jcrc.2025.155101_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2146\/ajhp160520","article-title":"Factors associated with availability of anticoagulation reversal agents in rural and community emergency departments","volume":"75","author":"Faine","year":"2018","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.jcrc.2025.155101_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231176808","article-title":"Reversal of oral anticoagulants: a survey of contemporary practice trends (ReACT)","volume":"29","author":"Deng","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"12","key":"10.1016\/j.jcrc.2025.155101_bb0125","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00134-021-06531-x","article-title":"Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine","volume":"47","author":"Vlaar","year":"2021","journal-title":"Intensive Care Med."},{"issue":"7","key":"10.1016\/j.jcrc.2025.155101_bb0130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jhm.13051","article-title":"Clinical guideline highlights for the hospitalist: 2022 American Heart Association\/American Stroke Association guideline for the management of patients with spontaneous intracerebral hemorrhage","volume":"18","author":"Burroughs-Ray","year":"2023","journal-title":"J. Hosp. Med."},{"issue":"1","key":"10.1016\/j.jcrc.2025.155101_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13054-023-04605-4","article-title":"Extracranial anticoagulant related bleedings admitted to intensive care units: a French multicenter retrospective study","volume":"27","author":"Botrel","year":"2023","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155101_bb0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"25","key":"10.1016\/j.jcrc.2025.155101_bb0145","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet alfa for the reversal of factor Xa inhibitor activity","volume":"373","author":"Siegal","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jcrc.2025.155101_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jcrc.2025.155101_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/21548331.2020.1753435","article-title":"Analysis of anticoagulation reversal survey (ARES)","volume":"48","author":"Rowe","year":"1995","journal-title":"Hosp. Pract."},{"issue":"1","key":"10.1016\/j.jcrc.2025.155101_bb0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1076029615598219","article-title":"Management strategies for vitamin K antagonists reversal in patients with major bleeding: a survey of Italian emergency departments","volume":"23","author":"Bernardi","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.jcrc.2025.155101_bb0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cll.2014.06.006","article-title":"Perioperative management of patients receiving new oral anticoagulants: an international survey","volume":"34","author":"Faraoni","year":"2014","journal-title":"Clin. Lab. Med."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:10:30Z","timestamp":1762312230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944125000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"alternative-id":["S0883944125000887"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155101","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of antithrombotics in the critically ill: An international online survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155101"}}